Nexus AG (0FGL.L)
EUR 71.3
(1.28%)
EUR 71.3
(1.28%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 24.76 Million EUR | 23.85% |
| 2022 | 28.49 Million EUR | 17.4% |
| 2021 | 24.26 Million EUR | 40.99% |
| 2020 | 17.21 Million EUR | -36.48% |
| 2019 | 27.09 Million EUR | 78.49% |
| 2018 | 15.18 Million EUR | 13.98% |
| 2017 | 13.31 Million EUR | 21.9% |
| 2016 | 10.92 Million EUR | 13.34% |
| 2015 | 9.64 Million EUR | 20.03% |
| 2014 | 8.03 Million EUR | 16.05% |
| 2013 | 6.92 Million EUR | 28.1% |
| 2012 | 5.4 Million EUR | 28.04% |
| 2011 | 4.21 Million EUR | 13.11% |
| 2010 | 3.73 Million EUR | 241.72% |
| 2009 | -2.63 Million EUR | -298.49% |
| 2008 | 1.32 Million EUR | 33.4% |
| 2007 | 994 Thousand EUR | 131.7% |
| 2006 | 429 Thousand EUR | -93.23% |
| 2005 | 6.33 Million EUR | 162.12% |
| 2004 | 2.41 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 10.7 Million EUR | 31.22% |
| 2024 Q1 | 8.39 Million EUR | -22.01% |
| 2024 Q2 | 8.15 Million EUR | -2.92% |
| 2023 Q1 | 8.32 Million EUR | -11.84% |
| 2023 Q4 | 10.77 Million EUR | 16.96% |
| 2023 FY | 35.28 Million EUR | 23.85% |
| 2023 Q3 | 9.2 Million EUR | 31.86% |
| 2023 Q2 | 6.98 Million EUR | -16.13% |
| 2022 Q2 | 6.4 Million EUR | 6.82% |
| 2022 Q1 | 5.99 Million EUR | -31.78% |
| 2022 Q4 | 9.44 Million EUR | 46.46% |
| 2022 FY | 28.49 Million EUR | 17.4% |
| 2022 Q3 | 6.44 Million EUR | 0.64% |
| 2021 FY | 24.26 Million EUR | 40.99% |
| 2021 Q3 | 4.99 Million EUR | -2.06% |
| 2021 Q2 | 5.09 Million EUR | 0.97% |
| 2021 Q4 | 8.79 Million EUR | 76.09% |
| 2021 Q1 | 5.04 Million EUR | 15.04% |
| 2020 Q1 | 4.33 Million EUR | -30.75% |
| 2020 FY | 17.21 Million EUR | -36.48% |
| 2020 Q4 | 4.38 Million EUR | 0.76% |
| 2020 Q3 | 4.35 Million EUR | 5.55% |
| 2020 Q2 | 4.12 Million EUR | -4.8% |
| 2019 Q4 | 6.26 Million EUR | 69.37% |
| 2019 Q3 | 3.69 Million EUR | 2.5% |
| 2019 Q2 | 3.6 Million EUR | -7.11% |
| 2019 FY | 27.09 Million EUR | 78.49% |
| 2019 Q1 | 3.88 Million EUR | -27.37% |
| 2018 Q3 | 3.23 Million EUR | -2.45% |
| 2018 Q2 | 3.31 Million EUR | 0.58% |
| 2018 Q1 | 3.29 Million EUR | -27.58% |
| 2018 Q4 | 5.34 Million EUR | 65.43% |
| 2018 FY | 15.18 Million EUR | 13.98% |
| 2017 Q1 | 2.92 Million EUR | -86.39% |
| 2017 FY | 13.31 Million EUR | 21.9% |
| 2017 Q2 | 2.96 Million EUR | 1.2% |
| 2017 Q3 | 2.88 Million EUR | -2.57% |
| 2017 Q4 | 4.54 Million EUR | 57.61% |
| 2016 Q1 | 2.59 Million EUR | -21.49% |
| 2016 Q4 | 21.5 Million EUR | 849.13% |
| 2016 Q3 | -2.87 Million EUR | -221.66% |
| 2016 Q2 | 2.35 Million EUR | -8.92% |
| 2016 FY | 10.92 Million EUR | 13.34% |
| 2015 FY | 9.64 Million EUR | 20.03% |
| 2015 Q4 | 3.29 Million EUR | 60.38% |
| 2015 Q3 | 2.05 Million EUR | -4.68% |
| 2015 Q2 | 2.15 Million EUR | 1.51% |
| 2015 Q1 | 2.12 Million EUR | -26.61% |
| 2014 Q4 | 2.89 Million EUR | 86.54% |
| 2014 Q3 | 1.55 Million EUR | -12.21% |
| 2014 Q2 | 1.76 Million EUR | -2.37% |
| 2014 FY | 8.03 Million EUR | 16.05% |
| 2014 Q1 | 1.81 Million EUR | -16.34% |
| 2013 Q3 | 1.5 Million EUR | -7.33% |
| 2013 Q1 | 1.62 Million EUR | 14.89% |
| 2013 FY | 6.92 Million EUR | 28.1% |
| 2013 Q4 | 2.16 Million EUR | 44.02% |
| 2013 Q2 | 1.62 Million EUR | -0.31% |
| 2012 Q1 | 1.29 Million EUR | 51.88% |
| 2012 Q2 | 1.45 Million EUR | 13.01% |
| 2012 Q3 | 1.23 Million EUR | -15.28% |
| 2012 Q4 | 1.41 Million EUR | 14.64% |
| 2012 FY | 5.4 Million EUR | 28.04% |
| 2011 FY | 4.21 Million EUR | 13.11% |
| 2011 Q1 | 981 Thousand EUR | -29.88% |
| 2011 Q4 | 850 Thousand EUR | -8.21% |
| 2011 Q2 | 1.46 Million EUR | 49.03% |
| 2011 Q3 | 926 Thousand EUR | -36.66% |
| 2010 Q2 | 639 Thousand EUR | -12.35% |
| 2010 Q3 | 991 Thousand EUR | 55.09% |
| 2010 Q4 | 1.39 Million EUR | 41.17% |
| 2010 Q1 | 729 Thousand EUR | 118.01% |
| 2010 FY | 3.73 Million EUR | 241.72% |
| 2009 Q2 | 379 Thousand EUR | -9.11% |
| 2009 Q1 | 417 Thousand EUR | 0.0% |
| 2009 FY | -2.63 Million EUR | -298.49% |
| 2009 Q4 | -4.04 Million EUR | -600.25% |
| 2009 Q3 | 809 Thousand EUR | 113.46% |
| 2008 FY | 1.32 Million EUR | 33.4% |
| 2007 FY | 994 Thousand EUR | 131.7% |
| 2006 FY | 429 Thousand EUR | -93.23% |
| 2005 FY | 6.33 Million EUR | 162.12% |
| 2004 FY | 2.41 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Cegedim SA | 19.98 Million EUR | -23.935% |
| Guerbet SA | 38.67 Million EUR | 35.957% |
| Bastide Le Confort Médical SA | 44.22 Million EUR | 43.996% |
| Revenio Group Oyj | 26.34 Million EUR | 5.986% |
| Drägerwerk AG & Co. KGaA | 171.18 Million EUR | 85.532% |
| Sartorius Aktiengesellschaft | 541 Million EUR | 95.422% |
| LNA Santé SA | 62.98 Million EUR | 60.677% |
| Siemens Healthineers AG | 2.86 Billion EUR | 99.137% |
| Medios AG | 31.37 Million EUR | 21.054% |
| Equasens Société anonyme | 55.2 Million EUR | 55.141% |
| Stratec SE | 22.88 Million EUR | -8.205% |